Migraine and multiple sclerosis: Epidemiology and approach to treatment

Multiple Sclerosis and Related Disorders

Volumn 2, Issue 2, 2013, Pages 73-79

  Gelfand, Amy A ^a   Gelfand, Jeffrey M ^a   Goadsby, Peter J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disease modifying therapy; Epidemiology; Headache; Migraine; Multiple sclerosis; Neuroimaging

Indexed keywords

ALEMTUZUMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA INTERFERON; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; FINGOLIMOD; FLUNARIZINE; GADOLINIUM; GLATIRAMER; NATALIZUMAB; NONSTEROID ANTIINFLAMMATORY AGENT; PEGINTERFERON BETA1A; PLACEBO; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

CAUSAL ATTRIBUTION; CLINICAL TRIAL (TOPIC); COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEADACHE; HEART DISEASE; HEREDITY; HUMAN; MIGRAINE; MIGRAINE AURA; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; WHITE MATTER LESION;

EID: 84872827627     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2012.10.003     Document Type: Review

References (80)

1. M. Absinta, M.A. Rocca, and B. Colombo Patients with migraine do not have MRI-visible cortical lesions Journal of Neurology 2012
2. A. Alonso, and M.A. Hernan Temporal trends in the incidence of multiple sclerosis: a systematic review Neurology 71 2008 129 135
3. S.K. Aurora, D.W. Dodick, and C.C. Turkel OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 2010 793 803
4. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120 (Pt 11):2059-69.
5. C. Confavreux, M. Hutchinson, M.M. Hours, P. Cortinovis-Tourniaire, and T. Moreau Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group New England Journal of Medicine 339 1998 285 291
6. J.A. Cohen, F. Barkhof, and G. Comi Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis New England Journal of Medicine 362 2010 402 415
7. A.J. Coles, D.A. Compston, and K.W. Selmaj Alemtuzumab vs. interferon beta-1a in early multiple sclerosis New England Journal of Medicine 359 2008 1786 1801
8. F. Cruz, S. Herschorn, and P. Aliotta Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial European Urology 60 2011 742 750
9. A. Cuomo-Granston, and P.D. Drummond Migraine and motion sickness: what is the link? Progress in Neurobiology 91 2010 300 312
10. H.C. Diener, D.W. Dodick, and S.K. Aurora OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 2010 804 814
11. H. Doi, T. Matsushita, N. Isobe, T. Ishizu, Y. Ohyagi, and J. Kira Frequency of chronic headaches in Japanese patients with multiple sclerosis: with special reference to opticospinal and common forms of multiple sclerosis Headache 49 2009 1513 1520
12. R. Foroozan, and F.M. Cutrer Transient neurologic dysfunction in migraine Neurologic Clinics 27 2009 361 378
13. FDA. FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod) [online]. Available from: 〈http://www.fda.gov/Drugs/ DrugSafety/ucm303192.htm〉. [accessed 11.01.2013].
14. M.S. Freedman, and T.A. Gray Vascular headache: a presenting symptom of multiple sclerosis Canadian Journal of Neurological Sciences 16 1989 63 66
15. Y.D. Fragoso, and J.B. Brooks Two cases of lesions in brainstem in multiple sclerosis and refractory migraine Headache 47 2007 852 854
16. J.R. Gee, J. Chang, AB Dublin, and N. Vijayan The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis Headache 45 2005 670 677
17. A.A. Gelfand, and P.J.A. Goadsby Neurologist's guide to acute migraine therapy in the emergency room Neurohospitalist 2 2012 51 59
18. J.M. Greer, and P.A. McCombe Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms Journal of Neuroimmunology 234 2011 7 18
19. P.J. Goadsby, J. Goldberg, and S.D. Silberstein Migraine in pregnancy British Medical Journal 336 2008 1502 1504
20. M.A. Grazko, K.B. Polo, and B. Jabbari Botulinum toxin A for spasticity, muscle spasms, and rigidity Neurology 45 1995 712 717
21. D.C. Haas, P.F. Kent, and D.I. Friedman Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area Headache 33 1993 452 455
22. S. Holland, S.D. Silberstein, F. Freitag, D.W. Dodick, C. Argoff, and E. Ashman Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society Neurology 78 2012 1346 1353
23. C.L. Harden, K.J. Meador, and P.B. Pennell Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the quality standards subcommittee and therapeutics and technology subcommittee of the American Academy of Neurology and the American Epilepsy Society Epilepsia 50 2009 1237 1246
24. J. Jankovic, and K. Schwartz Response and immunoresistance to botulinum toxin injections Neurology 45 1995 1743 1746
25. D.O. Kamson, Z. Illes, and M. Aradi Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis Journal of Clinical Neuroscience 19 2012 696 701
26. L. Kappos, E.W. Radue, and P. O'Connor A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis New England Journal of Medicine 362 2010 387 401
27. C.G. Katsiari, M. Vikelis, E.S. Paraskevopoulou, P.P. Sfikakis, and D.D. Mitsikostas Headache in systemic lupus erythematosus vs multiple sclerosis: a prospective comparative study Headache 51 2011 1398 1407
28. Z. Katsarava, and C. Weimar Migraine and stroke Journal of the Neurological Sciences 299 2010 42 44
29. I. Kister, A.B. Caminero, and T.S. Monteith Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course Journal of Headache and Pain 11 2010 417 425
30. I. Kister, A.B. Caminero, J. Herbert, and R.B. Lipton Tension-type headache and migraine in multiple sclerosis Current Pain and Headache Reports 14 2010 441 448
31. I. Kister, K.L. Munger, J. Herbert, and A. Ascherio Increased risk of multiple sclerosis among women with migraine in the nurses' Health Study II Multiple Sclerosis 18 2012 90 97
32. Y.E. Knight, and P.J. Goadsby The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience 106 2001 793 800
33. Kruit MC, van Burchem MA, Hofman PA, et al. Migraine as a risk factor for subcortical brain lesions. Journal of the American Medical Association 2004;291:427-34
34. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine: the population-based MRI CAMERA study. Brain 2005;128:2068-77
35. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006; 37:1109-12.
36. M.C. Kruit, M.A. van Buchem, L.J. Launer, G.M. Terwindt, and M.D. Ferrari Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study Cephalalgia 30 2010 129 136
37. T. Kurth, S. Mohamed, and P. Maillard Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study British Medical Journal 342 2011 c7357
38. R.B. Lipton, S. Diamond, M. Reed, M.L. Diamond, and W.F. Stewart Migraine diagnosis and treatment: results from the American Migraine Study II Headache 41 2001 638 645
39. D.W. Loring, D.J. Williamson, K.J. Meador, F. Wiegand, and J. Hulihan Topiramate dose effects on cognition: a randomized double-blind study Neurology 76 2011 131 137
40. H.J. Luijendijk, and X. Koolman The incentive to publish negative studies: how beta-blockers and depression got stuck in the publication cycle Journal of Clinical Epidemiology 65 2012 488 492
41. M. Leone, L. Grazzi, L. La Mantia, and G. Bussone Flunarizine in migraine: a minireview Headache 31 1991 388 391
42. R.B. Lipton, D. Dodick, and R. Sadovsky A self-administered screener for migraine in primary care: The ID Migraine validation study Neurology 61 2003 375 382
43. M. Lauritzen Pathophysiology of the migraine aura. The spreading depression theory Brain 117 1994 199 210 Pt 1
44. L. La Mantia Headache and multiple sclerosis: clinical and therapeutic correlations Neurological Sciences 30 1 2009 S23 26
45. R.B. Lipton, M.E. Bigal, M. Diamond, F. Freitag, M.L. Reed, and W.F. Stewart Migraine prevalence, disease burden, and the need for preventive therapy Neurology 68 2007 343 349
46. P. Mariotti, V. Nociti, and A. Cianfoni Migraine-like headache and status migrainosus as attacks of multiple sclerosis in a child Pediatrics 126 2010 e459 464
47. P. Mattsson Headache caused by drinking cold water is common and related to active migraine Cephalalgia 21 2001 230 235
48. D.D. Mikol, F. Barkhof, and P. Chang Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial Lancet Neurology 7 2008 903 914
49. A.V. Margulis, A.A. Mitchell, and S.M. Gilboa Use of topiramate in pregnancy and risk of oral clefts American Journal of Obstetrics and Gynecology 2012
50. H.J. Martinez Sobrepera, J.A. Cabrera Gomez, and A. Tuero Iglesias Exogenous factors in the aetiology of multiple sclerosis in Cuba. A study of cases and controls Revue Neurologique 33 2001 931 937
51. E.M. Melhado, J.A. Maciel Jr., and C.A. Guerreiro Headache during gestation: evaluation of 1101 women Canadian Journal of Neurological Sciences 34 2007 187 192
52. D. McAlpine, and N. Compston Some aspects of the natural history of disseminated sclerosis Quarterly Journal of Medicine 21 1952 135 167
53. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis Journal of the American Medical Association 296 2006 2832 2838
54. C.W. Noonan, S.J. Kathman, and M.C. White Prevalence estimates for MS in the United States and evidence of an increasing trend for women Neurology 58 2002 136 138
55. J.E. Norman Jr., J.F. Kurtzke, and G.W. Beebe Epidemiology of multiple sclerosis in U.S. veterans: 2. Latitude, climate and the risk of multiple sclerosis Journal of Chronic Diseases 36 1983 551 559
56. A. Nicoletti, F. Patti, and S. Lo Fermo Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily Cephalalgia 28 2008 1163 1169
57. P. O'Connor, M. Filippi, and B. Arnason 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study Lancet Neurology 8 2009 889 897
58. I.H. Palm-Meinders, H. Koppen, G.M. Terwindt, and L.J. Launder Journal of the American Medical Association 308 2012 1889 1897
59. C.H. Polman, P.W. O'Connor, and E. Havrdova A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis New England Journal of Medicine 354 2006 899 910
60. S. Prakash, N.C. Mehta, A.S. Dabhi, O. Lakhani, M. Khilari, and N.D. Shah The prevalence of headache may be related with the latitude: a possible role of Vitamin D insufficiency? Journal of Headache and Pain 11 2010 301 307
61. N. Putzki, A. Pfriem, and V. Limmroth Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis European Journal of Neurology 16 2009 262 267
62. N. Putzki, and Z. Katsarava Headache in multiple sclerosis Current Pain and Headache Reports 14 2010 316 320
63. L.A. Rolak, and S. Brown Headaches and multiple sclerosis: a clinical study and review of the literature Journal of Neurology 237 1990 300 302
64. B.K. Rasmussen, and J. Olesen Migraine with aura and migraine without aura: an epidemiological study Cephalalgia 12 1992 221 228 discussion 186
65. R.A. Rudick, W.H. Stuart, and P.A. Calabresi Natalizumab plus interferon beta-1a for relapsing multiple sclerosis New England Journal of Medicine 354 2006 911 923
66. W.F. Stewart, R.B. Lipton, and J. Liberman Variation in migraine prevalence by race Neurology 47 1996 52 59
67. S.D. Silberstein, S. Holland, F. Freitag, D.W. Dodick, C. Argoff, and E. Ashman Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society Neurology 78 2012 1337 1345
68. T. Sprenger, and P.J. Goadsby What has functional neuroimaging done for primary headache... and for the clinical neurologist? Journal of Clinical Neuroscience 17 2010 547 553
69. P. Tortorella, M.A. Rocca, B. Colombo, P. Annovazzi, G. Comi, and M. Filippi Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis Journal of the Neurological Sciences 244 2006 137 141
70. S.J. Tepper, C.G. Dahlof, and A. Dowson Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study Headache 44 2004 856 864
71. The International Classification of Headache Disorders. 2nd edition. Cephalalgia 2004;24 1:9-160.
72. V. Villani, L. Prosperini, C. Pozzilli, M. Salvetti, and G. Sette Quality of life of multiple sclerosis patients with comorbid migraine Neurological Sciences 32 1 2011 S149 151
73. H.L. Tremlett, and J. Oger Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS Neurology 61 2003 551 554
74. A. Van Der Walt, S. Sung, and T. Spelman A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor Neurology 79 2012 92 99
75. J.H. van Waesberghe, W. Kamphorst, and C.J. De Groot Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability Annals of Neurology 46 1999 747 754
76. V. Villani, L. Prosperini, C. Pozzilli, M. Salvetti, A. Ciuffoli, and G. Sette The use of ID migraine questionnaire in patients with multiple sclerosis Neurological Sciences 32 2011 269 273
77. G. Vacca, E. Marano, and V. Brescia Morra Multiple sclerosis and headache co-morbidity. A case-control study Neurological Sciences 28 2007 133 135
78. S.M. Watkins, and M. Espir Migraine and multiple sclerosis Journal of Neurology, Neurosurgery, and Psychiatry 32 1969 35 37
79. S. Warren, and K.G. Warren Multiple sclerosis and associated diseases: a relationship to diabetes mellitus Canadian Journal of Neurological Sciences 8 1981 35 39
80. M. Zorzon, R. Zivadinov, and D. Nasuelli Risk factors of multiple sclerosis: a case-control study Neurological Sciences 24 2003 242 247